Michela Serresi

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Cell States in Cancer: Drivers, Passengers, and Trailers.

Cell States in Cancer: Drivers, Passengers, and Trailers.

Journal: Cancer discovery
Published: April 04, 2024

Pharmacological modulators of epithelial immunity uncovered by synthetic genetic tracing of SARS-CoV-2 infection responses.

Pharmacological modulators of epithelial immunity uncovered by synthetic genetic tracing of SARS-CoV-2 infection responses.

Journal: Science advances
Published: June 21, 2023

Logical design of synthetic cis-regulatory DNA for genetic tracing of cell identities and state changes.

Logical design of synthetic cis-regulatory DNA for genetic tracing of cell identities and state changes.

Journal: Nature communications
Published: October 13, 2022

Functional antagonism of chromatin modulators regulates epithelial-mesenchymal transition.

Functional antagonism of chromatin modulators regulates epithelial-mesenchymal transition.

Journal: Science advances
Published: July 14, 2020

HNRNPM controls circRNA biogenesis and splicing fidelity to sustain cancer cell fitness.

HNRNPM controls circRNA biogenesis and splicing fidelity to sustain cancer cell fitness.

Journal: eLife
Published: June 04, 2020

Phenotypic Mapping of Pathologic Cross-Talk between Glioblastoma and Innate Immune Cells by Synthetic Genetic Tracing.

Phenotypic Mapping of Pathologic Cross-Talk between Glioblastoma and Innate Immune Cells by Synthetic Genetic Tracing.

Journal: Cancer discovery
Published: February 24, 2020

USP15 Deubiquitinase Safeguards Hematopoiesis and Genome Integrity in Hematopoietic Stem Cells and Leukemia Cells.

USP15 Deubiquitinase Safeguards Hematopoiesis and Genome Integrity in Hematopoietic Stem Cells and Leukemia Cells.

Journal: Cell reports
Published: January 29, 2020

Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities.

Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities.

Journal: The Journal of experimental medicine
Published: April 26, 2018

Polycomb and lung cancer: When the dosage makes the (kind of) poison.

Polycomb and lung cancer: When the dosage makes the (kind of) poison.

Journal: Molecular & cellular oncology
Published: February 03, 2016

Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer.

Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer.

Journal: Cancer cell
Published: March 12, 2015

In vivo shRNA screens in solid tumors.

In vivo shRNA screens in solid tumors.

Journal: Nature protocols
Published: November 21, 2014

Tight regulation of ubiquitin-mediated DNA damage response by USP3 preserves the functional integrity of hematopoietic stem cells.

Tight regulation of ubiquitin-mediated DNA damage response by USP3 preserves the functional integrity of hematopoietic stem cells.

Journal: The Journal of experimental medicine
Published: August 13, 2014
Showing 1-12 of 13

Last Updated: 09/26/2026